More articles from Interpreting Key Trials

  • Interpreting the ASTEROID Trial
    Ilke Sipahi MD, Stephen J. Nicholls MBBS, PhD, E. Murat Tuzcu MD and Steven E. Nissen MD
    Cleveland Clinic Journal of Medicine October 2006, 73 (10) 937-944;

    The optimal strategy for lipid-lowering in patients with coronary artery disease may be to aim for the lowest low-density lipoprotein cholesterol level that can be attained without adverse effects.